A Multi-Disciplinary Team Approach to the Management of Squamous Cell Carcinoma Wounds Supported by Bioactive Microfibre Gelling (BMG™) Technology
Publication Details:
Parker, J., Sweeney, R. & Burr, S. (n.d.) A multi-disciplinary team approach to the management of squamous cell carcinoma wounds supported by bioactive microfibre gelling (BMG™) technology Wound Care Today, E Poster,Dec.,2024.
Wound Details
Parker, J., Sweeney, R. & Burr, S. (n.d.) A multi-disciplinary team approach to the management of squamous cell carcinoma wounds supported by bioactive microfibre gelling (BMG™) technology Wound Care Today, E Poster,Dec.,2024.
Key Findings and Data:
- A showed significant improvement within 2.5 weeks, leading to near closure at 6 weeks.
- Managed overgranulation, biofilm, and exudate, with no adherencea to the wound bed.
- Medical imagery confirmed the improvements in wound healing.


Key Insights
- MaxioCel reduced clinic visits, improved patient comfort, and enhanced wound management.
- The MaxioCel’s ease of use, biofilm control, and cost-effectiveness make it a valuable addition to SCC wound care protocols.
- Now MaxioCel being considered for specialist wound care formulary inclusion.